ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FIXX Homology Medicines Inc

0.9347
0.00 (0.00%)
Apr 16 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.8911
Ask Price 0.9293
News -
Day High

Low
0.458

52 Week Range

High
1.48

Day Low
Company Name Stock Ticker Symbol Market Type
Homology Medicines Inc FIXX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.9347 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.9347 0.9347
Trades Volume Avg Volume 52 Week Range
0 0 - 0.458 - 1.48
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.9347 USD

Homology Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.34M - - - -48.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Homology Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FIXX Message Board. Create One! See More Posts on FIXX Message Board See More Message Board Posts

Historical FIXX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.860.97250.8550.9159719330,0080.07478.69%
3 Months0.61950.97250.58010.7843729461,3720.315250.88%
6 Months1.021.100.4580.7242815381,950-0.0853-8.36%
1 Year1.001.480.4580.9070953300,760-0.0653-6.53%
3 Years6.758.900.4583.36355,412-5.82-86.15%
5 Years22.7624.000.4588.01376,086-21.83-95.89%

Homology Medicines Description

Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Your Recent History

Delayed Upgrade Clock